| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |